Zenlabs Ethica Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 937253,
    "name": "Zenlabs Ethica",
    "stock_name": "Zenlabs Ethica",
    "full_name": "Zenlabs Ethica Ltd",
    "name_url": "stocks-analysis/zenlabs-ethica",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.50",
    "chg": 0.06,
    "chgp": "0.33%",
    "dir": 1,
    "prev_price": "18.44",
    "mcapval": "12.04 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530697,
    "symbol": "",
    "ind_name": "Diversified Commercial Services",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE546F01013",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "3.34 k",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenlabs-ethica-937253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Zenlabs Ethica Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-falls-to-52-week-low-of-rs1752-amidst-continued-underperformance-3910240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZenlabsEthicaLt_priceRelatedfactors_3910240.png",
        "date": "2026-03-24 10:56:44",
        "description": "While the broader market shows signs of recovery, Zenlabs Ethica Ltd has slipped to a fresh 52-week low of Rs 17.52, marking a 46.13% decline over the past year and underscoring persistent headwinds for the micro-cap player in the diversified commercial services sector."
      },
      {
        "title": "Zenlabs Ethica Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-valuation-shifts-signal-elevated-price-risk-amid-sector-challenges-3909077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZenlabsEthicaLt_valuationdot_3909077.png",
        "date": "2026-03-24 08:01:41",
        "description": "Zenlabs Ethica Ltd, a micro-cap player in the Diversified Commercial Services sector, has seen its valuation metrics shift markedly towards the expensive territory, raising concerns about price attractiveness for investors. Despite a modest day gain of 3.07%, the company’s price-to-earnings (P/E) ratio has surged to 53.16, signalling a significant premium compared to historical and peer averages. This article analyses the implications of these valuation changes in the context of Zenlabs Ethica’s financial performance and sector dynamics."
      },
      {
        "title": "Zenlabs Ethica Ltd Valuation Shifts Signal Price Attractiveness Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-valuation-shifts-signal-price-attractiveness-decline-3897933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZenlabsEthicaLt_valuationdot_3897933.png",
        "date": "2026-03-18 08:00:54",
        "description": "Zenlabs Ethica Ltd, a micro-cap player in the Diversified Commercial Services sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a recent downgrade to a Strong Sell rating, reflects evolving market perceptions and raises questions about the stock's price attractiveness relative to its historical and peer benchmarks."
      },
      {
        "title": "Zenlabs Ethica Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-challenges-3850564",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenlabsEthicaLt_valuationdot_3850564.png",
        "date": "2026-02-23 08:01:20",
        "description": "Zenlabs Ethica Ltd has seen a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. This change, driven primarily by a surge in its price-to-earnings (P/E) ratio and price-to-book value (P/BV), raises questions about the stock’s price attractiveness relative to its historical averages and peer group within the diversified commercial services sector."
      },
      {
        "title": "Zenlabs Ethica Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-valuation-shifts-signal-elevated-price-risk-amid-sector-challenges-3841756",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenlabsEthicaLt_valuationdot_3841756.png",
        "date": "2026-02-16 08:05:20",
        "description": "Zenlabs Ethica Ltd, a key player in the Diversified Commercial Services sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, raises questions about the stock’s price attractiveness amid subdued returns and a challenging industry backdrop."
      },
      {
        "title": "Zenlabs Ethica Ltd Valuation Shifts Signal Changing Market Perception",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-valuation-shifts-signal-changing-market-perception-3827889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenlabsEthicaLt_valuationdot_3827889.png",
        "date": "2026-02-09 08:02:12",
        "description": "Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and contrasting peer valuations, offering investors a fresh perspective on the stock’s price attractiveness."
      },
      {
        "title": "Are Zenlabs Ethica Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zenlabs-ethica-ltd-latest-results-good-or-bad-3826915",
        "imagepath": "",
        "date": "2026-02-07 19:21:30",
        "description": "Zenlabs Ethica Ltd's latest financial results for Q2 FY26 present a complex picture of operational challenges. The company reported a net profit of ₹0.04 crores, which reflects a sequential improvement of 33.33% from the previous quarter, but shows a significant decline of 20.00% compared to the same quarter last year. Revenue for the same period was ₹12.43 crores, marking an 8.28% increase quarter-on-quarter, yet this is accompanied by a year-on-year decline of 6.89%, indicating ongoing revenue pressures.\n\nThe profit after tax (PAT) margin remains extremely low at 0.32%, suggesting minimal profitability and a lack of buffer against operational disruptions. Additionally, the return on equity (ROE) has dropped to 2.37%, highlighting severe capital inefficiency and raising concerns about the company's ability to generate adequate returns for shareholders.\n\nThe operating profit margin also saw compression, dec..."
      },
      {
        "title": "Zenlabs Ethica Q2 FY26: Razor-Thin Margins and Persistent Losses Deepen Investor Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/zenlabs-ethica-q2-fy26-razor-thin-margins-and-persistent-losses-deepen-investor-concerns-3826789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenlabsEthica_quaterlyResult_3826789.png",
        "date": "2026-02-07 17:48:11",
        "description": "Zenlabs Ethica Ltd., a micro-cap pharmaceutical contract marketing and trading company, reported yet another quarter of anaemic profitability in Q2 FY26, with net profit standing at a meagre ₹0.04 crores on revenues of ₹12.43 crores. The stock, already languishing in bearish territory, has shed 46.54% over the past year and currently trades at ₹19.03, reflecting persistent investor scepticism about the company's ability to generate meaningful returns. With a market capitalisation of just ₹13.00 crores and a concerning pattern of margin compression, the Chandigarh-based firm faces mounting challenges in a competitive pharmaceutical distribution landscape."
      },
      {
        "title": "Zenlabs Ethica Ltd Valuation Shifts to Fair Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenlabs-ethica-ltd-valuation-shifts-to-fair-amidst-market-pressure-3815408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZenlabsEthicaLt_valuationdot_3815408.png",
        "date": "2026-02-02 08:03:04",
        "description": "Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this improvement, the company continues to face significant headwinds, reflected in its deteriorating returns and cautious market sentiment. This article analyses the latest valuation metrics, compares them with peers and historical benchmarks, and assesses the implications for investors."
      }
    ],
    "total": 75,
    "sid": "937253",
    "stock_news_url": "https://www.marketsmojo.com/news/zenlabs-ethica-937253"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-Mar-2026",
      "details": "Intimation of change in management due to Resignation of Company Secretary and Compliance Officer of the company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "02-Mar-2026",
      "details": "Intimation of Resignation of Company Secretary and Compliance Officer of the Company",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "23-Feb-2026",
      "details": "GST Demand Notice dated February 162026 has been received by the company on 23rd February2026 from the office of the Superintendent Range I Central Goods and Services Tax Division-1 Derabassi Government of Punjab imposing penalty and interest under Section 73 of the CGST Act.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zenlabs Ethica Ltd has declared <strong>2%</strong> dividend, ex-date: 29 Jul 22",
          "dt": "2022-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zenlabs Ethica Ltd has announced <strong>1:20</strong> bonus issue, ex-date: 11 Oct 18",
          "dt": "2018-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Markets Rally, But Zenlabs Ethica Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-24 10:56:44

While the broader market shows signs of recovery, Zenlabs Ethica Ltd has slipped to a fresh 52-week low of Rs 17.52, marking a 46.13% decline over the past year and underscoring persistent headwinds for the micro-cap player in the diversified commercial services sector.

Read full news article

Zenlabs Ethica Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges

2026-03-24 08:01:41

Zenlabs Ethica Ltd, a micro-cap player in the Diversified Commercial Services sector, has seen its valuation metrics shift markedly towards the expensive territory, raising concerns about price attractiveness for investors. Despite a modest day gain of 3.07%, the company’s price-to-earnings (P/E) ratio has surged to 53.16, signalling a significant premium compared to historical and peer averages. This article analyses the implications of these valuation changes in the context of Zenlabs Ethica’s financial performance and sector dynamics.

Read full news article

Zenlabs Ethica Ltd Valuation Shifts Signal Price Attractiveness Decline

2026-03-18 08:00:54

Zenlabs Ethica Ltd, a micro-cap player in the Diversified Commercial Services sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a recent downgrade to a Strong Sell rating, reflects evolving market perceptions and raises questions about the stock's price attractiveness relative to its historical and peer benchmarks.

Read full news article

Zenlabs Ethica Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Challenges

2026-02-23 08:01:20

Zenlabs Ethica Ltd has seen a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. This change, driven primarily by a surge in its price-to-earnings (P/E) ratio and price-to-book value (P/BV), raises questions about the stock’s price attractiveness relative to its historical averages and peer group within the diversified commercial services sector.

Read full news article

Zenlabs Ethica Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges

2026-02-16 08:05:20

Zenlabs Ethica Ltd, a key player in the Diversified Commercial Services sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, raises questions about the stock’s price attractiveness amid subdued returns and a challenging industry backdrop.

Read full news article

Zenlabs Ethica Ltd Valuation Shifts Signal Changing Market Perception

2026-02-09 08:02:12

Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change reflects evolving market perceptions amid a challenging price performance and contrasting peer valuations, offering investors a fresh perspective on the stock’s price attractiveness.

Read full news article

Are Zenlabs Ethica Ltd latest results good or bad?

2026-02-07 19:21:30

Zenlabs Ethica Ltd's latest financial results for Q2 FY26 present a complex picture of operational challenges. The company reported a net profit of ₹0.04 crores, which reflects a sequential improvement of 33.33% from the previous quarter, but shows a significant decline of 20.00% compared to the same quarter last year. Revenue for the same period was ₹12.43 crores, marking an 8.28% increase quarter-on-quarter, yet this is accompanied by a year-on-year decline of 6.89%, indicating ongoing revenue pressures. The profit after tax (PAT) margin remains extremely low at 0.32%, suggesting minimal profitability and a lack of buffer against operational disruptions. Additionally, the return on equity (ROE) has dropped to 2.37%, highlighting severe capital inefficiency and raising concerns about the company's ability to generate adequate returns for shareholders. The operating profit margin also saw compression, dec...

Read full news article

Zenlabs Ethica Q2 FY26: Razor-Thin Margins and Persistent Losses Deepen Investor Concerns

2026-02-07 17:48:11

Zenlabs Ethica Ltd., a micro-cap pharmaceutical contract marketing and trading company, reported yet another quarter of anaemic profitability in Q2 FY26, with net profit standing at a meagre ₹0.04 crores on revenues of ₹12.43 crores. The stock, already languishing in bearish territory, has shed 46.54% over the past year and currently trades at ₹19.03, reflecting persistent investor scepticism about the company's ability to generate meaningful returns. With a market capitalisation of just ₹13.00 crores and a concerning pattern of margin compression, the Chandigarh-based firm faces mounting challenges in a competitive pharmaceutical distribution landscape.

Read full news article

Zenlabs Ethica Ltd Valuation Shifts to Fair Amidst Market Pressure

2026-02-02 08:03:04

Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this improvement, the company continues to face significant headwinds, reflected in its deteriorating returns and cautious market sentiment. This article analyses the latest valuation metrics, compares them with peers and historical benchmarks, and assesses the implications for investors.

Read full news article

View All News